• Light-Activated Cancer Drugs

    At the University of Kentucky, Assistant Professor of Chemistry Edith "Phoebe" Glazer is looking for something more effective at killing cancer cells and less toxic to healthy cells than cisplatin. Her alternative uses ruthenium to build complex molecules that can be "switched on" by light from a fiber-optic probe once they reach their target tumor. In January 2013, Glazer received a four-year, $715,000 grant from the American Cancer Society to develop a family of ruthenium molecules to fight different kinds of cancer. Learn more »

videos

Hazard Map

KGS Challenges USGS Seismic Hazard Map

  • May 23, 2013

Jim Cobb and Zhenming Wang proved the USGS's math was wrong. Kentucky's hazard wasn't so high...

Learn More »
child doing puzzle

UK Research Yields Effective Autism Education Program

  • May 6, 2013

Lisa Ruble's research led to individualized education plans for children with autism...

Learn More »
Peixuan Guo

UK's Guo Discovers New Class of Revolving Biomotor

  • May 1, 2013

Peixuan Guo’s discovery may lead to man-made nanomedical devices to treat individual diseased cells...

Learn More »
Samson Cheung

What's Next: Online Security

  • May 1, 2013

Samson Cheung in the College of Engineering is finding new ways to secure your online identify...

Learn More »
Project CARAT

Project CARAT: Medical Equipment Recycling

  • April 18, 2013

CARAT helps people who are uninsured or underinsured acquire recycled assistive technology...

Learn More »
Peter Zhou

UK Study Shows Key Enzyme Missing from Triple-Negative Breast Cancer

  • March 21, 2013

Peter Zhou found that triple-negative breast cancer cells are missing a key enzyme...

Learn More »